News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–8
Matches
8
Sources here
6
Companies here
1
Search results Stored financial headlines

Active search

8 matching headlines

Ticker or company: MDCXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Medicus To Continue Phase 2 For SkinJect In Carcinoma With FDA Recommendations; Stock Falls 12%

(RTTNews) - Medicus Pharma Inc. (MDCX), a biotech/life sciences company, on Tuesday announced the receipt of a 'Study May Proceed' notification from the U.S. Food and Drug Administration (FDA), allowing for the initiation of the Phase 2b SKNJCT-005 trial evaluating SkinJect in Gorlin syndrome. …

MDCX main company
Sharemaestro market context Price below Trend Line 52 weeks -87.4% · Next-week setup negative 31.3% MDCX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

PHILADELPHIA, July 27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic assets, today announced that the U.S. Food and Drug Administration (“FDA”) …

MDCX main company
Sharemaestro market context Price below Trend Line 52 weeks -87.4% · Next-week setup negative 31.3% MDCX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context